ClinicalTrials.gg
CompletedNCT04513691Updated Nov 22, 2022

A Chart Review of Newborns With the Presence of Confirmed or Suspected Maternal Chorioamnionitis and Utilization of the Early Onset Sepsis Calculator

An observational study in Maternal; Chorioamnionitis, Affecting Fetus and Early-Onset Sepses, Neonatal, sponsored by Pediatrix. Completed at 1 site in United States. Open to participants aged 35 Weeks and older. Per ClinicalTrials.gov, last updated 2022-11-22.

Sponsored by Pediatrix · Observational

Study type
Observational
Model
Cohort
Time perspective
Cross-sectional
Enrollment
236
Ages
35 Weeks and older
Sex
All
01

Study summary

This study will review practices in relation to chorioamnionitis (CAM) before and after to the implementation of the Neonatal Early-Onset Sepsis (EOS) Risk Calculator to determine the effect in the nursery at Banner - University Medical Center Phoenix. Newborns enrolled will be at least 35 weeks gestational age (GA) and have a maternal diagnosis of at least suspected or confirmed CAM. The data will include those newborns whose assessment and treatment were not guided by the EOS calculator which was implemented on August 28, 2019 and those with which the EOS calculator was utilized. A secondary objective is to show the economic impact with utilization of the EOS calculator. Data collected will include full laboratory workups including complete blood counts (CBC), blood cultures, antibiotic usage, length of time in the newborn nursery and total length of stay.

02

Conditions studied

  • Maternal; Chorioamnionitis, Affecting Fetus
  • Early-Onset Sepses, Neonatal
03

In context

Chorioamnionitis

39 studies on the registry are indexed under Chorioamnionitis; 9 are open to participants now.

This study's enrollment of 236 is above the median of 125 across 14 observational studies indexed under Chorioamnionitis.

Browse Chorioamnionitis studies →

Lead sponsor

Pediatrix is the lead sponsor of 34 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
35 Weeks and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Asymptomatic newborns 35 weeks or greater GA born at Banner - University Medical Center Phoenix April 28, 2018 through April 28, 2020 whose mothers were determined or suspected to have CAM.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Asymptomatic newborns 35 weeks or greater GA born at Banner - University Medical Center Phoenix whose mothers were determined or suspected to have CAM.

Exclusion criteria

Exclusion Criteria:

  • Direct NICU Admissions
  • Subjects may be excluded at Investigator discretion
05

Study design

Observational model
Cohort
Time perspective
Cross-sectional
Enrollment
236 participants (actual)
Patient registry
No

Groups and cohorts

  • Sample

    Asymptomatic newborns 35 weeks or greater GA born at Banner - University Medical Center Phoenix whose mothers were determined or suspected to have CAM.

    Diagnostic Test: EOS Calculator

Interventions

  • Diagnostic testEOS Calculator

    Neonatal Early-Onset Sepsis Risk Calculator which is a tool that determines the risk of EOS for a particular newborn by looking at maternal risk factors and the newborn's clinical picture as opposed to just laboratory tests alone

06

What researchers measure

Primary outcomes

  1. To determine whether the usage of Neonatal EOS Calculator decreased antibiotic usage in newborns with a maternal diagnosis of suspected or confirmed chorioamnionitis (CAM) in our newborn nursery.

    To determine the usage of EOS Calculator measuring decreased antibiotic usage.

    Time frame: August 28, 2018 through August 28, 2020

  2. To determine whether the usage of Neonatal EOS Calculator measuring laboratory testing in newborns with a maternal diagnosis of suspected or confirmed chorioamnionitis (CAM) in our newborn nursery.

    To determine the usage of EOS Calculator measuring laboratory testing.

    Time frame: August 28, 2018 through August 28, 2020

  3. To determine whether the usage of Neonatal EOS Calculator LOS in newborns with a maternal diagnosis of suspected or confirmed chorioamnionitis (CAM) in our newborn nursery.

    To determine the usage of EOS Calculator measuring length of stay (LOS) in newborns

    Time frame: August 28, 2018 through August 28, 2020

Secondary outcomes

  1. To evaluate the economic impact after the implementation of the EOS Calculator in antibiotic usage in newborn nursery and total length of hospital stay.

    Evaluate the economic impact after the implementation of the EOS Calculator in antibiotic usage.

    Time frame: August 28, 2018 through August 28, 2020

  2. To evaluate the economic impact after the implementation of the EOS Calculator in laboratory tests in newborn nursery and total length of hospital stay.

    Evaluate the economic impact after the implementation of the EOS Calculator in laboratory tests.

    Time frame: August 28, 2018 through August 28, 2020

  3. To evaluate the economic impact after the implementation of the EOS Calculator in LOS in newborn nursery and total length of hospital stay.

    Evaluate the economic impact after the implementation of the EOS Calculator LOS in newborn nursery and total length of hospital stay.

    Time frame: August 28, 2018 through August 28, 2020

07

Study locations

1 site
  • Banner - University Medical Center Phoenix
    Phoenix, Arizona 85006, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Nov 22, 2022, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04513691
Lead sponsor
Pediatrix
Collaborators
Banner University Medical Center
Responsible party
Sponsor
First posted
Aug 14, 2020
Start date
Sep 30, 2020
Primary completion
Aug 10, 2022
Completion
Aug 10, 2022
Last update
Nov 22, 2022

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2022. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion